In this case-based activity, leading clinical investigator Oliver Sartor, MD examines recent developments and best practices in treatment selection and supportive care planning for patients with metastatic castration-resistant prostate cancer.
CME-certified online activity
Watch this CME/CE certified discussion with Tanya Dorff, MD from the Keck School of Medicine as she discusses progress in our understanding of predictive/prognostic markers in advanced prostate cancer as well as optimizing treatment sequencing and response assessment. Participate from the comfort of your home or office.
CME or CE credit available